United States
US 12,702,668 B2
Method for treating graft versus host disease caused by hematopoietic stem cell transplantation
US 12,702,668 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: BEIJING TIDE PHARMACEUTICAL CO., LTD. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- BEIJING TIDE PHARMACEUTICAL CO., LTD.
- Inventors
- Cheung Ling CHENG; Yanping ZHAO; Hongjun WANG; Weiting ZHONG; Jing LI; Jing ZHAO; Weina LIU
- Publication date
- 2026-08-11
- Filing date
- 2023-01-20
- Document type
- B2 Granted patent
- Also written as
- US 12,702,668 B2 · US12702668 · 12702668
Abstract
A method for preventing, alleviating and/or treating graft versus host disease caused by hematopoietic stem cell transplantation, which comprises administering an effective amount of a compound of formula (I), or a pharmaceutically acceptable salt, ester, stereoisomer, polymorph, solvate, N-oxide, isotope-labeled compound, metabolite or prodrug thereof to an individual in need thereof.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free